Pharmaceutical Manufacturing Market Size, Share & Growth Analysis Report By Drug Development Type (In-house and Outsource), By Route of Administration (Topical, Oral, Inhalations, Parenteral, and Others), By Formulation (Injectable, Tablets, Suspensions, Capsules, Sprays, and Others), By Therapy (Diabetes, Cardiovascular Diseases, Respiratory Diseases, Cancer, Pain, and Others) - Global Industry Analysis, Trends, Segment Forecasts, Regional Outlook 2021 - 2030


The global pharmaceutical manufacturing market size was accounted at US$ 357.9 billion in 2020 and is predicted to surpass around US$ 1,173.3 billion by 2030.

The pharmaceutical manufacturing market is globally growing at a noteworthy CAGR of 12.8% during the forecast period 2021 to 2030.

Pharmaceutical Manufacturing Market Size 2017 to 2030

Major Trends In The Pharmaceutical Manufacturing Industry:

Pharmaceutical manufacturing is described as the method of commercial-scale coalescence of medications by the pharmaceutical companies. Medication manufacturing services are outlined by a core assurance to meeting the user’s objectives with the finest quality while sustaining the most effective use of time and regulating costs. The pharmaceutical industry has the repute of being watchful about applying new technology and very slow to carry out changes. The cautious approach of pharma industry is because of the regulatory obligations to verify that any procedure modifications will not exhibit a harmful effect on the product quality. However, the monitoring agencies along with pharma industry are attempting to adopt procedures and technologies that will advance quality and production efficiency. Moreover, there is also a consciousness that more adjustments will be required to further acclimatize to new manufacturing methods, such as continuous manufacturing, personalized medicine, and Industry 4.0,along with subsidiary technologies, such as procedure analytics and innovative process control. Leading pharmaceutical manufacturers are exploiting advanced technologies for streamlining manufacturing processes. For example, GSK is evolving world-class manufacturing modernization for bringing drugs and other healthcare products to persons who want them all over the world. The company is employing progressive technologies to advance the skill within manufacturing, installing virtual reality devices and touch screens to preserve a sterile atmosphere and bolster apparatus maintenance.

Crucial factors accountable for market growth are:

  • Increasing prevalence of chronic ailments
  • Growing geriatric population
  • High investment in research and development
  • Increasing focus on outsourcing manufacturing activities
  • Increasing per capita healthcare expenditure
  • Growing incidence of novel viral diseases
  • Technological advancements in manufacturing processes
  • Improving reimbursement scenario in developing regions

COVID-19 Impact on Global Pharmaceutical Manufacturing Market

The corona virus pandemic has tested the Pharmaceutical industry by presenting challenges such as speeding up research activities, expansion of manufacturing capacities, and supply chains. The sudden up burst in all sectors of pharmaceutical industry, has bought the attention of investors around the globe to this sector. The pharmaceutical manufacturers have realigned their strategies to deal with the pandemic situation in a better way. The development of vaccine against the corona virus in a record time-span is an accurate example of the steps taken by manufacturers to combat the pandemic. The development of multiple rapid testing methods for early detection of COVID-19 has also played a major role in containing the disease. The leading companies within healthcare domain are working with governments across the world to prepare an effective framework for avoidance of such pandemics in the future.

Future of Pharmaceutical Manufacturing

In order to deal with the challenges that advanced therapeutics, pricing burdens, and worldwide supply chains exhibit, the implementation of latest digital solutions has become vital for pharmaceutical manufacturers. It includes leveraging artificial intelligence, Big Data, machine-learning, and industrial internet of things (IIoT)for a consequential impact on pharmaceutical manufacturing process to improve quality. Contract manufacturing is expected to bring about the much-required transformation in the pharmaceutical manufacturing business.

Report Highlights Details
Market Size US$ 1,173.3 Billion by 2030
Growth Rate CAGR of 12.8% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Drug Development, Route of Administration, Formulation, Therapy
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned GlaxoSmithKline plc, Merck & Co., Inc., Eli Lilly and Company, Johnson & Johnson, Hoffmann-La Roche Ltd., Lonza, Pfizer, Inc., Sanofi SA, Novartis AG, AstraZeneca

Significant Market Trends:

In-house Segment Reported Foremost Market Stake in 2019

In-house drug development segment displayed the major share in the worldwide pharmaceutical manufacturing market in 2019. The use of in-house infrastructure and expertise by big pharma companies for drug development is the major reason for high market share of multi-dose systems. The factors such as data privacy issues and technological advancements are expected to retain the dominance of in-house drug development in the near future.

The outsourced drug development is projected grow at the highest CAGR through the forecast time-frame mainly due togrowing popularity of contract research organizations.

Oral Route of Administration Dominated the Market Revenue

Oral drugs are prescribed for a vast-array of diseases due to their easy availability and affordability. Oral medicines are generally the first line of treatment that a physician prescribes.Thus, high incidence of chronic ailments such as diabetes and asthma are expected to boost the demand for oral medicines in the forecast time-frame.

Parenteral segment will expand at a significant CAGR during the forecast time-frame.

Tablets Will Dominate the Formulation Segment of Pharmaceutical Manufacturing Market Revenue

Tablets are the most widely used formulation due to factors such as ease of storage and use. Furthermore, tablets are available in multiple forms for different purposes. These factors contribute to the growth of tablets segment.

Cancer Accounted For the Highest Share within the Therapy Segment of Pharmaceutical Manufacturing Market Revenue

Factors such as high investment in cancer research, strong product pipeline, and technological improvements contribute to the growth of cancer segment.

Global Pharmaceutical Manufacturing Market 2021 to 2030

North America is Estimated to be the Largest Market for Pharmaceutical Manufacturing

The research study covers key prospects and trends of pharmaceutical manufacturing products throughout different regions including Europe, North America, Asia-Pacific, Middle East and Africa, and Latin America. Regionally, pharmaceutical manufacturing market is dominated by North America due to presence of skilled researchers and high prevalence of chronic ailments. Europe accounted for the second highest share majorly due to encouraging reimbursement scenario and high geriatric population. On the other hand, Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing investment by major manufacturers, rising popularity of contract research organizations, and growing per-capita healthcare expenditure.

Top Players contending in the Market:

The companies focusing on research and development are expected to lead the global pharmaceutical manufacturing market. Leading competitors contending in global pharmaceutical manufacturing market are as follows:

  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Hoffmann-La Roche Ltd.
  • Lonza
  • Pfizer, Inc.
  • Sanofi SA
  • Novartis AG
  • AstraZeneca

In order to better recognize the current status of pharmaceutical manufacturing, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the pharmaceutical manufacturing market. This research study bids qualitative and quantitative insights on pharmaceutical manufacturing market and assessment of market size and growth trend for potential market segments.

Key Market Developments:

  • In December 2020, Aprecia entered into a collaboration with Battelle to fast-track and expand its proficiencies in the 3D printed pharmaceutical manufacturing.

Major Market Segments Covered:

By Drug Development Type

  • In-house
  • Outsource

By Route of Administration

  • Topical
  • Oral
  • Inhalations
  • Parenteral
  • Others

By Formulation

  • Injectable
  • Tablets
  • Suspensions
  • Capsules
  • Sprays
  • Others

By Therapy

  • Diabetes
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Cancer
  • Pain
  • Others

By Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa
Request for Customize Report
Precedence offers custom market research services that help clients to get information on their business scenario required.

Frequently Asked Questions

What is the current size of the global pharmaceutical manufacturing market?
According to Precedence Research, the global pharmaceutical manufacturing market size was valued at US$ 357.9 billion in 2020 and is expected to surpass around US$ 1,173.3 billion by 2030.
The pharmaceutical manufacturing market is anticipated to grow at a noteworthy CAGR of 12.8% during the forecast period 2021 to 2030.
Factors such as increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, increasing focus on outsourcing manufacturing activities, increasing per capita healthcare expenditure, growing incidence of novel viral diseases, technological advancements in manufacturing processes, and improving reimbursement scenario in developing regions are driving the growth of pharmaceutical manufacturing market.
In 2019, North America dominated the global market with a market share of more than 41%
Asia Pacific is estimated to advance at the maximum CAGR of around 15.8% in the forecast period due to high incidence of chronic ailments.
In-house drug development segment displayed the major share in the worldwide pharmaceutical manufacturing market in 2019.
The oral route of administration accounted for the largest revenue in the containers segment with more than 68% share in 2020.
The major companies operating in the worldwide pharmaceutical manufacturing market are GlaxoSmithKline plc, Merck & Co., Inc., Eli Lilly and Company, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Lonza, Pfizer, Inc., Sanofi SA, Novartis AG, and AstraZeneca among others.

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence client

Get a Sample